Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

653
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
653
Drug Therapy01:28

Drug Therapy

376
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
376
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

1.1K
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
1.1K
Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

1.2K
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
1.2K
Antipsychotic Drugs: Therapeutic Uses and Side Effects01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

1.1K
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
1.1K
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

316
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
316

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Machine Learning-Based Audiovisual Phenotyping for Measuring Communication, Shared Decision-Making, and Trust.

JMIR formative research·2026
Same author

Implementing Point-of-Care Fingerstick Testing for Clozapine Safety Monitoring in Outpatient Psychiatry: A Convergent Mixed Methods Study.

Community mental health journal·2026
Same author

A Mixed Methods Study of Program-Level Factors Influencing Patient and Family Engagement in First Episode Psychosis Coordinated Specialty Care.

medRxiv : the preprint server for health sciences·2026
Same author

Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I: A Review of the Pharmacokinetic Literature and Proposed Changes.

Journal of clinical psychopharmacology·2025
Same author

Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II: A Review of Fatal Outcomes in US Pharmacovigilance Data and Proposed Changes.

Journal of clinical psychopharmacology·2025
Same author

Smartphone Screen Time Characteristics in People With Suicidal Thoughts: Retrospective Observational Data Analysis Study.

JMIR mHealth and uHealth·2024
Same journal

Unanticipated Effects of Parental Social Media Use: Guidance for Clinicians.

Psychiatric services (Washington, D.C.)·2026
Same journal

Learning About Stigma From Inside the Classroom.

Psychiatric services (Washington, D.C.)·2026
Same journal

Characteristics of Clinical Supervision Associated With Improvements in Youth Outcomes in Community Mental Health Clinics.

Psychiatric services (Washington, D.C.)·2026
Same journal

VA Health Care Utilization Among U.S. Veterans: The Influence of Social Determinants of Health and Health Factors.

Psychiatric services (Washington, D.C.)·2026
Same journal

Defining Digital Peer Support: A Framework to Preserve Core Values in the Rush to Digitize.

Psychiatric services (Washington, D.C.)·2026
Same journal

Perspectives of Individuals With Lived Experience on Obsessive-Compulsive Disorder Treatment Delivery, Supports, and Research.

Psychiatric services (Washington, D.C.)·2026
See all related articles

Related Experiment Video

Updated: Mar 18, 2026

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans
07:35

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans

Published on: February 4, 2014

12.0K

Clozapine Monitoring: Form Follows Function.

Abigail L Donovan1,2, Cheryl Y S Foo1,2, Carol Lim1,2

  • 1Psychosis Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, Boston.

Psychiatric Services (Washington, D.C.)
|March 17, 2026
PubMed
Summary
This summary is machine-generated.

The clozapine REMS program is gone, allowing for a new monitoring system. This system uses a three-phase framework with shared decision-making for clozapine treatment.

Keywords:
AntipsychoticsClozapineMedical MonitoringMedical-Psychiatric IntegrationSchizophrenia

More Related Videos

Author Spotlight: Studying Drug Impacts on Brain Signals Using Dual LFP Recording Protocol in Mice
04:44

Author Spotlight: Studying Drug Impacts on Brain Signals Using Dual LFP Recording Protocol in Mice

Published on: February 16, 2024

2.3K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.8K

Related Experiment Videos

Last Updated: Mar 18, 2026

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans
07:35

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans

Published on: February 4, 2014

12.0K
Author Spotlight: Studying Drug Impacts on Brain Signals Using Dual LFP Recording Protocol in Mice
04:44

Author Spotlight: Studying Drug Impacts on Brain Signals Using Dual LFP Recording Protocol in Mice

Published on: February 16, 2024

2.3K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.8K

Area of Science:

  • Psychiatry and Pharmacology
  • Treatment Monitoring Systems

Background:

  • The clozapine Risk Evaluation and Mitigation Strategies (REMS) program has been eliminated.
  • This elimination creates a need for a revised clozapine monitoring approach.

Purpose of the Study:

  • To propose a new conceptual framework for clozapine monitoring.
  • To integrate medical and psychiatric care through a phased treatment model.

Main Methods:

  • The proposed system is structured into three distinct phases: clozapine trial, treatment optimization, and treatment consolidation.
  • Each phase features specific treatment goals and monitoring schedules.
  • Shared decision-making involving prescribers, patients, and families/guardians is central to each phase's initiation.

Main Results:

  • The new framework facilitates a structured approach to clozapine management.
  • Reverse medical-psychiatric integration is incorporated throughout the treatment phases.
  • Therapeutic decision points are established for evaluating treatment options.

Conclusions:

  • The proposed three-phase monitoring system offers a structured alternative to the previous clozapine REMS program.
  • This model emphasizes integrated care and patient-centered decision-making for clozapine therapy.
  • The framework supports optimized and consolidated clozapine treatment.